title: Economic evaluation and end-stage renal disease: from basics to bedside.
abstract: Economic evaluation is the comparative analysis of alternative health care interventions in terms of their relative costs (resource use) and effectiveness (health effects). High-quality studies of economic evaluation have been increasingly published in medical journals and read by clinicians, although publication of these studies in nephrology journals has been a more recent phenomenon. This article shows how the basic principles of economics can be applied to health care through the use of economic evaluation. Different types of economic evaluation are discussed, and pitfalls common to such studies are identified. A simple framework is introduced that can be used to interpret the results of economic evaluations. Using this framework, selected therapies for patients with end-stage renal disease (ESRD) are categorized to highlight therapies that are very efficient, encourage their use, and draw attention to therapies in current use that are less effective and more expensive (ie, less efficient) than alternative therapy. Using examples pertinent to care of the patient with ESRD, we show how economic evaluation can be used to link medical outcomes, quality of life, and costs in a common index for multiple therapies with disparate outcome measures. This article highlights the need for clinical studies and economic evaluations of therapies in ESRD for which the effects of the therapy on health outcomes and/or costs are unknown.
authors.affiliation: Department of Medicine, Division of Nephrology, and the Departments of Community Health Sciences and Economics, The University of Calgary, Calgary, Canada.
authors.forename: B J
authors.initials: BJ
authors.lastname: Manns
authors.forename: K J
authors.initials: KJ
authors.lastname: Taub
authors.forename: C
authors.initials: C
authors.lastname: Donaldson
mesh_terms: D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006295:Health Resources / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000191:economics* / Q000628:therapy; D019057:Quality-Adjusted Life Years; D016896:Treatment Outcome; D014481:United States